checkAd
    ONCODESIGN PRECISION MEDICINE Aktie
    1,2950
     
    EUR
    +0,39 %
    +0,0050 EUR
    Letzter Kurs 20.05.24 Frankfurt
    1,1700
     
    EUR
    1.710 STK
    Geldkurs 07:30:43
    1,4300
     
    EUR
    1.399 STK
    Briefkurs 07:30:43
    ISIN: FR001400CM63 · WKN: A3DVNM · SYM: ZR8 · Frankreich

    Neueste Nachrichten

    Oncodesign Precision Medicine and Navigo Proteins GmbH Sign a Strategic Collaboration Agreement for the Research and Development of New Systemic Radiotherapy Agents
    15.05.24 · Business Wire (engl.) · ONCODESIGN PRECISION MEDICINE
    Degroof Petercam Initiates Coverage of Oncodesign Precision Medicine
    18.04.24 · Business Wire (engl.) · ONCODESIGN PRECISION MEDICINE
    Oncodesign Precision Medicine (OPM) obtains €5.6 million in public funding for its DEMOCRITE program dedicated to the clinical development of OPM-101
    17.04.24 · Business Wire (engl.) · ONCODESIGN PRECISION MEDICINE
    OPM Publishes Its Annual Results for 2023 and Provides an Update on Its Clinical Developments
    26.03.24 · Business Wire (engl.) · ONCODESIGN PRECISION MEDICINE
    Oncodesign Precision Medicine Obtains Deep Tech Development Funding for Its ANIMUS Program
    29.02.24 · Business Wire (engl.) · ONCODESIGN PRECISION MEDICINE
    Oncodesign Precision Medicine receives ERDF fund totalling €2.1 M for its COMETE program
    25.01.24 · Business Wire (engl.) · ONCODESIGN PRECISION MEDICINE
    TP ICAP Midcap Initiates Coverage of Oncodesign Precision Medicine With a “Buy” Recommendation
    12.12.23 · Business Wire (engl.) · ONCODESIGN PRECISION MEDICINE
    Oncodesign Precision Medicine Announces a 6 Million Euros Bank Financing from Caisse d’Épargne Bourgogne Franche Comté, Crédit Agricole de Champagne Bourgogne and Société Générale
    05.10.23 · Business Wire (engl.) · ONCODESIGN PRECISION MEDICINE
    OPM Announces Positive Interim Results of Its Phase 1 Study Evaluating OPM-101 in Healthy Volunteers
    02.10.23 · Business Wire (engl.) · ONCODESIGN PRECISION MEDICINE
    OPM Announces Its Results for the First Half of 2023
    19.09.23 · Business Wire (engl.) · ONCODESIGN PRECISION MEDICINE
    Oncodesign Precision Medicine: Report of the annual General Meeting of 30 May 2023
    30.05.23 · Business Wire (engl.) · ONCODESIGN PRECISION MEDICINE